The median survival for patients in the tertile with the lowest rate of weight loss was 30.2 months; the median survival for those in the intermediate weight-loss tertile was 10.2 months; and the median survival for those patients with the fastest rate of weight loss was 7.5 months (P<0.0001, log-rank test).
Both low- and intermediate-CORT groups exhibited weight loss at the time of ADX surgery, and neither recovered to the level of sham animals (Table 1), consistent with previous long-term ADX studies (20, 84).
Among those with partial adherence to metformin, weight loss was intermediate between the highly adherent group and those on placebo.
Serpine−/+ mice exhibited an intermediate phenotype with respect to weight loss, survival, and murine lung PAI-1 levels, indicating a co-dominant effect of PAI-1 on IAV infection.
Rats in the moderate weight loss group had intermediate values.
Early translational diabetes prevention studies conducted in Finland, Germany and the US assessed weight loss as an intermediate health outcome, thus assuming that weight loss, achieved through these interventions delivered to high-risk individuals, would predict reduced T2D incidence.
Cachexia progression was studied in Apc(Min/+) mice that were either weight stable (WS) or had initial (≤5%), intermediate (6-19%), or extreme (≥20%) body weight loss.
Bringing us to modern day banding, we will scrutinize the short-term weight loss result and how weight loss is maintained during the intermediate time period.
88 In our clinical experience, unrealistic weight loss expectations may be easily changed later when patients have reached some intermediate goals and the rate of weight loss is declining.
